Mediplast

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of corns and calluses, providing relief from pain associated with these conditions. It is also indicated for the removal of common warts, which are characterized by a rough, 'cauliflower-like' appearance on the surface. Additionally, this drug is indicated for the removal of plantar warts, which are specifically located on the bottom of the foot and are recognized by their tenderness and the disruption they cause to the footprint pattern.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be washed thoroughly, and it is recommended to soak the corn, callus, or wart in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. The medicated pad should be cut to fit the size of the corn, callus, or wart before application.

Once prepared, the medicated pad should be applied directly to the affected area. It is important to remove the medicated pad after 48 hours. This procedure may be repeated every 48 hours for a duration of up to 14 days for the removal of corns and calluses. For warts, the treatment may be continued for up to 12 weeks, or until the condition has resolved.

Contraindications

Use is contraindicated in the following situations:

• Patients with diabetes or poor blood circulation, due to the increased risk of complications.

• Application on irritated skin or any area that is infected or reddened, as this may exacerbate the condition.

• Use on moles, birthmarks, or warts with hair growing from them, as well as genital warts, facial warts, or warts located on mucous membranes (including those inside the mouth, nose, anus, genitals, or lips) is contraindicated to prevent potential adverse effects.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate professional assistance should be sought, or contact a Poison Control center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists for more than 72 hours.

This product should not be used in the following circumstances:

• In individuals with diabetes or those who exhibit poor blood circulation.

• On skin that is irritated or on any area that shows signs of infection or redness.

• On moles, birthmarks, or warts that have hair growing from them, as well as genital warts, warts located on the face, or warts on mucous membranes, including those found inside the mouth, nose, anus, genitals, or lips.

These precautions are essential to ensure the safe and effective use of the product.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated in individuals who are diabetic or have poor blood circulation. Additionally, the product should not be applied to irritated skin or any area that is infected or reddened. It is also advised against using the product on moles, birthmarks, or warts with hair growing from them, as well as genital warts, warts on the face, and warts on mucous membranes, including those inside the mouth, nose, anus, genitals, or lips.

Patients are instructed to discontinue use and consult a healthcare professional if discomfort persists for more than 72 hours.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mediplast (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored to ensure that this medication is kept out of reach. In the event of accidental ingestion, it is crucial to seek professional assistance or contact a Poison Control center immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients or those planning to become pregnant should not use this medication. The potential risks associated with its use during pregnancy have not been established, and there may be unknown fetal impacts. Healthcare professionals are advised to counsel women of childbearing potential regarding the importance of effective contraception during treatment and to discuss the implications of pregnancy while on this medication.

Lactation

There are no specific warnings or recommendations regarding the use of MEDIPLAST in lactating mothers. Additionally, there is no information available about the potential for excretion of MEDIPLAST in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or a medical toxicologist for guidance on management strategies tailored to the individual patient's needs.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with unintentional exposure in young children.

In the event of accidental ingestion, healthcare providers should instruct patients to seek professional assistance or contact a Poison Control center immediately. Prompt action is crucial to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in its original packaging, which should be retained until use to ensure optimal stability and efficacy. It is essential to store the product at room temperature, away from direct light exposure, to maintain its integrity. Once opened, the product must be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mediplast, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)